Cytokinetics Inc. buy JPMorgan Chase & Co.
Start price
20.01.26
/
50%
€54.00
Target price
20.01.27
€63.57
Performance (%)
0.00%
Price
23.01.26
€54.00
Summary
This prediction is currently active. JPMorgan_Chase___Co_'s BUY prediction for Cytokinetics Inc. is currently unchanged. This prediction currently runs until 20.01.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Cytokinetics Inc. | 0.00% |
| iShares Core DAX® | -1.764% |
| iShares Nasdaq 100 | -1.632% |
| iShares Nikkei 225® | -2.451% |
| iShares S&P 500 | -2.252% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at JPMorgan Chase & Co. from $70.00 to $74.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
09.06.25
09.06.25
€46.41
09.06.26
09.06.26
86.21%
23.01.26
23.01.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€50.50
05.09.24
05.09.24
€63.96
05.09.25
05.09.25
-9.31%
06.09.25
06.09.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€49.60
24.06.24
24.06.24
€60.52
24.06.25
24.06.25
-42.74%
25.06.25
25.06.25

